About aerosol therapy
Aerosol therapy is recognised as an effective and important medical treatment option for a range of pathologies of the respiratory tract.
The effectiveness, and quality of aerosol therapy depends on three main factors:
Median particle size measured as MMAD (Mass Median Aerodynamic Diameter)
Proportion of the medication that is broken down into fine enough particles to reach the lungs FPF (Fine Particle Fraction < 5µm)
How quickly the device can break down the prescribed dose of medication into breathable particles.
Uncompromising aerosol therapy with Flaem
Flaem works closely with highly specialised laboratories and prestigious international universities to produce high quality devices that deliver effective aerosol therapy. When helping a patient choose a nebulising device, factors to consider include the patient’s prescription, therapy frequency and budget.
NebulAir+ heavy-duty compressors are available for patients who need treatment multiple times per day or for medical facilities that require ongoing use of the compressors. Read more.
RespirAir is a lightweight, user-friendly device perfect for those who require a highly effective nebuliser for quality treatment at home. Read more.
Smarty is a compact, quiet hand-held nebuliser with revolutionary vibrating mesh technology. It is great for active patients who need aerosol therapy on the go. Read more.
The following table provides a quick selection guide you can use:
MMAD: Mass Median Aerodynamic Diameter.
FPF: Fine Particle Fraction, fraction of the particles below 5µm.